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Perspective
I
n the late 1990s and early 21st 
century, some public health 
officials in the Western world 
believed that Africans would never be 
compliant with antiretroviral therapy 
(ART) because the continent’s 
uneducated, illiterate population was 
driven by day-to-day concerns without 
much thought for the long-term 
future. On top of this, many claimed 
that ART was a luxury for Africans and 
that the complex disease would be too 
difficult for African doctors to manage 
in the middle of nowhere with no 
water or electricity. Some went so far 
as to insist that giving ART to a likely 
noncompliant population would create 
drug resistance and were willing to 
sacrifice Africa for the good of global 
public health [1].
However, recent research has shown 
that levels of adherence to ART in sub-
Saharan Africa are in fact higher than 
those in North America [2]. Why are 
Africans with HIV more adherent to 
ART than their counterparts in North 
America despite being less educated 
about HIV and having more obstacles 
to overcome? A new study by Norma 
Ware and colleagues published in 
PLoS Medicine sets out to answer this 
complicated question [3]. This study 
investigates the surprising finding that 
Africans would want to take drugs that 
would give them life and keep them 
healthy. Anthropologically, this first 
question leads to another complex 
question: Why is it that when things are 
successful in Africa the rest of the world 
looks for a reason, but when things fail, 
there are few who question the failure?
The New Study
Ware and colleagues asked patients, 
treatment partners (those who 
assisted patients in their efforts to 
take antiretroviral medications), and 
health care providers what the driving 
factors were behind adherence in three 
sites: (1) The Immune Suppression 
Syndrome clinic at Mbarara University 
of Science and Technology in Mbarara, 
Uganda; (2) the ART clinic of Amana 
District Hospital in Dar es Salaam, 
Tanzania; and (3) the HIV/AIDS clinic 
at Jos University Teaching Hospital in 
Jos, Nigeria. Patient interviews focused 
on experiences with taking ART, clinic 
visits, and help from treatment partners. 
Treatment partner interviews targeted 
the types of help that they give, feelings 
about being a treatment partner, and 
opinions on their impact. Health care 
workers, such as clinicians, nurses, and 
others, were asked to describe typical 
clinic visits, ways adherence is discussed 
at these visits, and views of patient 
obstacles towards adherence. The 
researchers also conducted observations 
of clinic visits, with a focus on observing 
routine follow-up visits of patients 
taking ART, counseling sessions, health 
education sessions, and the dispensing 
of antiretroviral medications. In all, 158 
patients, 45 treatment partners, and 49 
health care workers were interviewed. 
There were 414 interviews and 136 
observation sessions conducted across 
the three sites.
The study shows that Africans 
overcome economic obstacles to get 
ART by begging and borrowing money 
from friends, families, and even their 
health care providers. They may choose 
to use money for transportation for 
their clinic appointments over food for 
them or their family, over school fees 
for their children, and over treatment 
for their sick child. Patients without 
money would take their medications 
without food despite the increased risk 
of side effects and would walk to health 
clinics despite long distances. Health 
care providers also made sacrifices by 
keeping their offices open longer to 
accommodate patients who arrived late 
and gave food, money, and even loans 
to needy patients.
The study also shows the significant 
impact of social responsibility upon 
adherence. Families and friends often 
help finance health needs, but this 
assistance becomes more difficult to 
justify if it is believed the patient is 
near death or incurable. Treatment 
partners insisted on adherence to 
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Linked Research Article
This Perspective discusses the 
following new study published in PLoS
Medicine:
Ware NC, Idoko J, Kaaya S, Biraro 
IA, Wyatt MA, et al. (2009) Explaining 
adherence success in sub-Saharan 
Africa: An ethnographic study. PLoS Med 
6(1): e1000011. doi:10.1371/journal.
pmed.1000011
Using ethnographic data from Nigeria, 
Tanzania, and Uganda, Norma Ware 
and colleagues examine why levels of 
adherence to HIV/AIDS drugs are so 
much higher in sub-Saharan Africa than 
in North America.PLoS Medicine  |  www.plosmedicine.org 0011 January 2009  |  Volume 6  |  Issue 1  |  e1000018
ART by those they cared for because it 
made the treatment partner’s burden 
lighter. The treatment partners’ help 
created an obligation to patients 
to be adherent. Some health care 
providers threatened to discontinue 
giving treatment to nonadherent 
clients, further emphasizing the social 
responsibility patients had to remain 
adherent.
Public Health Implications
Ware and colleagues’ multi-country, 
multi-setting study used a methodology 
of interpersonal interaction that 
allowed people to talk simply to the 
researchers, without complicated study 
designs getting in the way. Instead 
of coming with experts and boxes to 
check, the researchers captured the 
viewpoint of the patient, treatment 
partner, and grassroots-level health 
care worker. The findings show the 
importance of social capital (the 
connections between people) and 
reveal that social responsibility in 
Africa pushes people to be “good” 
(adherent) patients. Social capital 
has been used in other countries such 
as Rwanda, where those who want 
treatment must come to the clinic 
with a relative or members of their 
association.
Those who have truly been working 
in Africa should not have learned 
anything new. Social capital can be 
easily seen in day-to-day health care 
work. This new study will, however, 
hopefully change the way the rest 
of the world views Africa. The study 
proves that human rights activists were 
correct in believing that giving ART 
in underdeveloped settings does not 
put the world in danger. When future 
myths about Africa are presented, 
people can point to this study to show 
that the uneducated, illiterate, and 
poor still want to survive, perhaps even 
more than those in Europe or the 
United States. Although this study does 
not change policies and will not affect 
future clinical decisions, it can be a 
useful tool to create support for access 
to treatment in Africa. 
Social coercion in Africa is high 
because people are more responsible 
for each other. Yes, Africans want to 
live, but more than that, they want to 
keep their relationships alive. Patients 
living with HIV in North America 
often have negative experiences and 
complicated backgrounds, such as 
traumatic events and mental illness, 
with little social support, and they 
face a great deal of stigma [4]. Social 
capital is less strong in the United 
States than in Africa as people in the 
US tend to be more individualistic 
and therefore less focused upon and 
connected to the group as a whole. 
There is less concern about others 
and less of a feeling that others are 
concerned about you. Ware and 
colleagues state that: “In North 
America, adherence to ART for HIV/
AIDS has been interpreted as the 
product of information, motivation, 
and behavioral skills operating at the 
individual level.” In other words, the 
driving factor for Americans to take 
their drugs is not social responsibility, 
but intellectualization of what to do to 
remain alive. Patients take the drugs 
they are given for themselves and not 
for others. Therefore, when a patient 
becomes depressed, adherence often 
declines. Research has shown that 
depressed people living with HIV 
progress to AIDS faster than those 
who are not depressed, due in part to 
nonadherence [5]. In Africa, on the 
other hand, taking prescribed ART is 
a community effort. Even when patients 
no longer care for themselves, they 
continue to take the medication for 
the community around them. 
Next Steps
Having clearly established the 
importance of social capital in 
promoting adherence to ART, 
future studies should focus both on 
its protective effects outside of the 
scope of HIV/AIDS and on how to 
maintain social capital while improving 
economic development, which can 
bring a more individualistic way of 
life. A developed economy provides 
an environment that allows the growth 
of individualism, while the poor tend 
to depend on their community for 
survival. Social capital can be a useful 
tool in promoting adherence to 
medications in patients with chronic 
diseases, who are at higher risk of 
depression than the general population 
[6]. As countries in Africa become 
more economically developed, it will be 
increasingly more important for them 
to actively find tools to maintain their 
social capital.  
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